Opthea (FRA:UKJ) Days Sales Outstanding

: 1,525.18 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

Opthea's average Accounts Receivable for the six months ended in Dec. 2023 was €0.47 Mil. Opthea's Revenue for the six months ended in Dec. 2023 was €0.06 Mil. Hence, Opthea's Days Sales Outstanding for the six months ended in Dec. 2023 was 1,525.18.

The historical rank and industry rank for Opthea's Days Sales Outstanding or its related term are showing as below:

FRA:UKJ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 680.12 Med: 2074.42 Max: 2151.46
Current: 2059.94

During the past 13 years, Opthea's highest Days Sales Outstanding was 2151.46. The lowest was 680.12. And the median was 2074.42.

FRA:UKJ's Days Sales Outstanding is ranked worse than
98.31% of 887 companies
in the Biotechnology industry
Industry Median: 72.66 vs FRA:UKJ: 2059.94

Opthea's Days Sales Outstanding declined from Dec. 2022 (2,852.96) to Dec. 2023 (1,525.18).

Opthea Days Sales Outstanding Historical Data

The historical data trend for Opthea's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 678.38 [6] => 1,256.44 [7] => 2,058.73 [8] => 1,990.52 [9] => 2,146.20 )

Opthea Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

678.38

1,256.44

2,058.73

1,990.52

2,146.20

Opthea Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding																2,046.28	1,775.23	2,852.96	2,688.37	1,525.18

Competitive Comparison

For the Biotechnology subindustry, Opthea's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opthea Days Sales Outstanding Distribution

For the Biotechnology industry and Healthcare sector, Opthea's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Opthea's Days Sales Outstanding falls into.

Opthea Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Opthea's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0	+	0.588)	/	1 )	/	0.1	*	365
=	0.588					/	0.1	*	365
=	2,146.20

Opthea's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0.468)	/	1 )	/	0.056	*	365 / 2
=	0.468					/	0.056	*	365 / 2
=	1,525.18

Opthea (FRA:UKJ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Opthea Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Opthea's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Opthea (FRA:UKJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (FRA:UKJ) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

OPT:USA OPT:Australia

Address

650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141

Website

https://www.opthea.com

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

Opthea (FRA:UKJ) Headlines

No Headlines